MarketFriction

Dolphin Medical Services Ltd

BSE 526504 · Healthcare Service Provider
₹6.61 +4.92%
BSE close2026-09-28
Market cap₹9.98 Cr.
P/E166

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.180.200.140.140.250.240.140.170.180.210.190.21
Expenses0.170.200.270.130.230.230.190.140.160.180.170.18
Operating Profit0.010.00-0.130.010.020.01-0.050.030.020.030.020.03
OPM %5.56%0.00%-92.86%7.14%8.00%4.17%-35.71%17.65%11.11%14.29%10.53%14.29%
Other Income0.010.010.010.010.010.010.010.010.010.010.010.01
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.010.010.010.010.010.010.030.010.030.030.020.02
Profit before tax0.010.00-0.130.010.020.01-0.070.030.000.010.010.02
Tax %0.00%7.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.010.00-0.130.010.020.01-0.070.030.010.020.010.02
EPS in Rs0.010.00-0.090.010.010.01-0.050.020.010.010.010.01
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.570.350.150.060.180.470.520.610.680.780.750.79
Expenses0.390.330.230.200.526.240.660.690.760.780.630.69
Operating Profit0.180.02-0.08-0.14-0.34-5.77-0.14-0.08-0.080.000.120.10
OPM %31.58%5.71%-53.33%-233.33%-188.89%-1,227.66%-26.92%-13.11%-11.76%0.00%16.00%12.66%
Other Income0.150.020.09-0.630.055.550.040.040.040.040.040.04
Interest0.060.010.010.010.010.010.010.010.010.010.010.00
Depreciation0.340.330.330.240.060.060.060.060.050.060.090.10
Profit before tax-0.07-0.30-0.33-1.02-0.36-0.29-0.17-0.11-0.10-0.030.060.04
Tax %-28.57%-10.00%-12.12%-1.96%5.56%6.90%5.88%9.09%10.00%0.00%0.00%
Net Profit-0.05-0.27-0.30-1.01-0.39-0.31-0.19-0.12-0.10-0.030.060.06
EPS in Rs-0.03-0.18-0.20-0.67-0.26-0.21-0.13-0.08-0.07-0.020.040.04
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth3%10%7%-1%
Compounded Profit Growth12%17%36%700%
Stock Price CAGR20%19%53%206%
Return on Equity-2%-1%0%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital15.1015.1015.1015.1015.1015.1015.1015.1015.1015.1015.1015.10
Reserves-2.30-2.34-2.61-2.91-3.91-4.30-4.61-4.80-4.92-5.03-5.06-5.02
Borrowings8.058.168.218.216.226.370.610.680.760.800.870.87
Other Liabilities0.740.670.650.610.580.711.231.261.231.271.171.48
Total Liabilities21.5921.5921.3521.0117.9917.8812.3312.2412.1712.1412.0812.43
Fixed Assets14.5010.3610.039.706.796.743.002.942.872.832.766.91
CWIP2.145.935.935.935.935.934.094.094.094.094.090.31
Investments0.520.520.410.410.410.410.410.410.410.410.410.41
Other Assets4.434.784.984.974.864.804.834.804.804.814.824.80
Total Assets21.5921.5921.3521.0117.9917.8812.3312.2412.1712.1412.0812.43
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.05-0.12-0.070.000.02-0.130.27-0.10-0.07-0.05-0.060.14
Cash from Investing Activity0.000.010.030.001.97-0.010.000.000.000.000.00-0.45
Cash from Financing Activity-0.050.110.050.00-1.990.15-0.250.070.070.050.060.31
Net Cash Flow0.000.000.000.000.000.010.03-0.020.000.000.000.00
Free Cash Flow0.05-0.11-0.070.001.99-0.140.27-0.10-0.07-0.05-0.06-0.31
CFO/OP-167%-56%-200%0%-14%38%-5%71%88%62%117%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days0.000.000.000.000.000.000.000.000.000.000.000.00
Inventory Days36.5021.470.000.000.000.000.000.000.0033.1830.4236.50
Days Payable73.000.000.000.000.00
Cash Conversion Cycle-36.5021.470.000.000.000.000.000.000.0033.1830.4236.50
Working Capital Days1,449.861,171.842,106.574,891.0011,619.173,629.72986.28898.46771.89687.06645.77515.87
ROCE %-2.55%-0.05%-0.96%-1.56%-1.69%-2.02%-1.98%-1.45%-0.91%-0.83%-0.18%0.64%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters26.44%26.44%26.44%26.44%26.44%26.44%26.44%26.44%26.44%26.44%26.44%26.44%
Public73.56%73.56%73.57%73.56%73.57%73.57%73.57%73.57%73.57%73.57%73.57%73.56%
No. of Shareholders9,1369,3609,3499,3589,3499,3499,3499,3499,3499,3499,34910,111

Fundamentals

Market Cap₹ 9.98 Cr.
Current Price₹ 6.61
Stock P/E166
Book Value₹ 6.68
ROCE0.64 %
ROE0.60 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-1%
Compounded Profit Growth (TTM)700%
Standalone figures.
Valuation
Market capRs 10 Cr
Enterprise valueRs 11 Cr
P/E (TTM)166.33x
Price to book0.99x
Price to sales12.63x
EV / EBITDA63.71x
EV / EBIT154.71x
EV / sales13.71x
Price to cash flow71.29x
Earnings yield0.60%
P/B, 3-year average0.37x
P/B, 5-year average0.32x
Profitability
Operating margin (excl. other income)16.00%
Operating margin (incl. other income)21.33%
EBITDA margin21.52%
Pre-tax margin7.59%
Net profit margin7.59%
Net margin, latest quarter9.52%
ROE0.60%
ROCE0.64%
ROA0.49%
ROE, 3-year average-0.23%
ROCE, 3-year average-0.12%
ROA, 3-year average-0.19%
ROE, 5-year average-0.74%
ROCE, 5-year average-0.55%
ROA, 5-year average-0.62%
ROIC (approx.)0.64%
Other income / net worth0.40%
Growth
Sales growth (latest year)-3.85%
Sales CAGR, 3 years7.13%
Sales CAGR, 5 years9.80%
Sales growth QoQ10.53%
Profit growth QoQ100.00%
Sales growth YoY (latest quarter)23.53%
Profit growth YoY (latest quarter)-33.33%
Per share
EPS (TTM)Rs 0.04
EPS (latest quarter)Rs 0.01
EPS, 3-year averageRs -0.04
EPS, 5-year averageRs -0.07
Book value per shareRs 6.68
Sales per shareRs 0.52
Cash flow per shareRs 0.09
Free cash flow per shareRs -0.21
Efficiency
Asset turnover0.06x
Fixed asset turnover0.11x
Inventory turnover10.00x
Inventory days36 days
Creditor days0 days
Cash conversion cycle36 days
Working capital days516 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 0 Cr
Net debtRs 1 Cr
Debt to equity0.09x
Net debt / EBITDA5.00x
Interest coverage7.00x
Owners' fund to total sources81.09%
Debt to assets7.00%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Sales to cash flow5.36x
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 1 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 1 Cr
Total income (latest year)Rs 1 Cr
Share capitalRs 15 Cr
ReservesRs -5 Cr
Shareholders' fundsRs 10 Cr
Total assetsRs 12 Cr
Net blockRs 7 Cr
Capital work in progressRs 0 Cr
InvestmentsRs 0 Cr
InventoryRs 0 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)1.51
Ownership
Promoter holding26.44% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.99 is at the 96th percentile (median 0.24).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period526504Nifty 50Difference
1 week-8.2%-2.8% -5.4 pts
1 month+11.8%-6.8% +18.6 pts
3 years+257.3%+14.2% +243.1 pts
5 years+127.1%+27.9% +99.3 pts

Red flags

F-score 7 of 8
lookProfit leans on other income Other income was 67% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr +23.5% vs Jun 2025. Net profit ₹0 Cr -33.3%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Dolphin Medical Services Ltd?

Dolphin Medical Services Ltd (526504) has a market capitalisation of Rs 9.98 Cr. at the 2026-09-28 close.

What is the P/E ratio of Dolphin Medical Services Ltd?

Dolphin Medical Services Ltd trades at a P/E of 166 on trailing twelve-month profit, at the 2026-09-28 close.

What were Dolphin Medical Services Ltd's latest quarterly results?

In the Jun 2026 quarter, Dolphin Medical Services Ltd sales was Rs 0 Cr (+23.5% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03